Evaluation of Acoustic Membrane Microparticle (AMMP) Technology for a Sensitive Ligand Binding Assay to Support Pharmacokinetic Determinations of a Biotherapeutic

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 6

Abstract

Achieving the required sensitivity can be a challenge in the development of ligand binding assays for pharmacokinetic (PK) determinations of biotherapeutics. To address this need, BioScale’s Acoustic Membrane Microparticle (AMMP) technology was evaluated for the quantification of a PEGylated domain antibody (dAb) biotherapeutic. Previous uses of this technology had shown utility in biomarker and process development applications and this is the first application, to our knowledge, for PK determinations. In this evaluation, AMMP was capable of delivering a sensitivity of 0.750 ng/mL, which surpasses the sensitivity requirements for the majority of assays to support PK determinations. This evaluation demonstrates that this emerging technology has the ability to produce the required sensitivity, reproducibility, and selectivity needed to meet the industry’s standards for PK analysis.

Authors and Affiliations

Shannon D. Chilewski, W. Matthew Dickerson, Johanna R. Mora, Ashley Saab, Edward M. Alderman

Keywords

Related Articles

Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand

In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-m...

Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies

Over the last few years, numerous ligand binding assay technologies that utilize real-time measurement have been introduced; however, an assemblage and evaluation of these technologies has not previously been published....

A Review of Imaging Agent Development

This educational review highlights the processes, opportunities, and challenges encountered in the discovery and development of imaging agents, mainly positron emission tomography and single-photon emission computed tomo...

Universal Immunoassay Applied During Early Development of Large Molecules to Understand Impact of Immunogenicity on Biotherapeutic Exposure

The online version of this article (doi:10.1208/s12248-012-9403-0) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681743
  • DOI  10.1208/s12248-014-9659-7
  • Views 73
  • Downloads 0

How To Cite

Shannon D. Chilewski, W. Matthew Dickerson, Johanna R. Mora, Ashley Saab, Edward M. Alderman (2014). Evaluation of Acoustic Membrane Microparticle (AMMP) Technology for a Sensitive Ligand Binding Assay to Support Pharmacokinetic Determinations of a Biotherapeutic. The AAPS Journal, 16(6), -. https://europub.co.uk/articles/-A-681743